title: [Feasibility analysis of endostatin combined with chemotherapy in the treatment of metastatic angiosarcoma].
authors.affiliation: Email: hopeful2003@126.com.
authors.forename: Yongxia
authors.initials: Y
authors.lastname: Cui
authors.forename: Zhifen
authors.initials: Z
authors.lastname: Luo
authors.forename: Chuangxin
authors.initials: C
authors.lastname: Lu
authors.forename: Bing
authors.initials: B
authors.lastname: Bai
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D000077143:Docetaxel; D043169:Endostatins / Q000627:therapeutic use*; D015251:Epirubicin / Q000008:administration & dosage; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006394:Hemangiosarcoma / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008875:Middle Aged; D011630:Pubic Bone / Q000473:pathology*; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D043169:Endostatins; D043823:Taxoids; D000077143:Docetaxel; D015251:Epirubicin